Avanir Pharmaceutical Inc-Takeover Target

Discussion in 'Avanir Pharmaceuticals' started by Anonymous, May 2, 2014 at 6:59 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    In light of recent developments with Avanir and Pharma M&A activity hearing up, someone will be knocking on the door if not already. Question is who and at what premium.
     

  2. Anonymous

    Anonymous Guest

    Just in hours ago.
    I can not see Avanir going below the $7-$8 range. Let's see what the near term future brings us, sector is full of surprises each day.

    LONDON (Reuters) - U.S. drugmaker Pfizer has raised its offer for AstraZeneca to 63 billion pounds ($106 billion), it said on Friday, adding that the British drugmaker was reviewing the proposal.
     
  3. Anonymous

    Anonymous Guest

    This is the AVANIR board, not the AstraZeneca board.
    We only have 1 drug with a very small an limited indication.
    I doubt anyone wants to buy us yet.
     
  4. Anonymous

    Anonymous Guest

    You need to see the forest thru the trees. PBA is the first of many indications to come. Company will look a lot different in a year if we haven't been bought out by then.
     
  5. Anonymous

    Anonymous Guest

    Why should $AVNR sell for $7-8 pps when stock will easily be in double digit $pps range by EOY '14? Neudexta patent win, expanding indications, and new formulations will drive serious revenue growth.
     
  6. Anonymous

    Anonymous Guest

    Don't forget about our multi-dose approval in EU. Revenues will begin this year.
     
  7. Anonymous

    Anonymous Guest

    Go find another site to poison....